The Effect of Dry Eye Disease on Scar Formation in Rabbit Glaucoma Filtration Surgery

被引:9
作者
Ji, Hong [1 ]
Zhu, Yingting [1 ]
Zhang, Yingying [1 ]
Jia, Yu [1 ]
Li, Yiqing [1 ]
Ge, Jian [1 ]
Zhuo, Yehong [1 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China
关键词
dry eye disease; scar formation; glaucoma; filtration surgery; rabbit; OCULAR SURFACE DISEASE; TGF-BETA; FIBROSIS; CELLS; MODEL; EXPRESSION; SYMPTOMS; SIGNS; MEDICATION; IL-1-BETA;
D O I
10.3390/ijms18061150
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The success rate of glaucoma filtration surgery is closely related to conjunctival inflammation, and the main mechanism of dry eye disease (DED) is inflammation. The aim of this study was to evaluate the effect of DED on bleb scar formation after rabbit glaucoma filtration surgery. Sixteen New Zealand white rabbits were randomly divided into control and DED groups. A DED model was induced by twice-daily topical administration of 0.1% benzalkonium chloride (BAC) drops for three weeks. Ocular examinations were performed to verify the DED model. Surgical effects were assessed, and histologic assessments were performed on the 28th postoperative day. Higher fluorescein staining scores, lower basal tear secretion levels and goblet cell counts, and increased interleukin 1 beta (IL-1 beta) levels were observed in the DED group. The DED eyes displayed significantly higher intraocular pressure (IOP)% on the 14th postoperative day; a smaller bleb area on days 14, 21 and 28; and a shorter bleb survival time. Moreover, proliferating cell nuclear antigen (PCNA) and alpha-smooth muscle actin (-SMA) levels were significantly increased in the DED group. These results demonstrate that DED promotes filtering bleb scar formation and shortens bleb survival time; these effects may be mediated via IL-1 beta.
引用
收藏
页数:14
相关论文
共 49 条
  • [1] Dry Eye Disease: Present Challenges in the Management and Future Trends
    Al-Saedi, Zahraa
    Zimmerman, Allison
    Bachu, Rinda Devi
    Dey, Surajit
    Shah, Zahoor
    Baugh, Reginald
    Boddu, Sai H. S.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (28) : 4470 - 4490
  • [2] [Anonymous], ADV HEMATOL, DOI DOI 10.1371/J0URNAL.P0NE.0030026
  • [3] Epithelial mucins of the ocular surface:: Structure, biosynthesis and function
    Argüeso, P
    Gipson, IK
    [J]. EXPERIMENTAL EYE RESEARCH, 2001, 73 (03) : 281 - 289
  • [4] Baudouin C, 2017, DEV OPHTHALMOL, V59, P67, DOI 10.1159/000458487
  • [5] Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension
    Baudouin, Christophe
    Renard, Jean-Paul
    Nordmann, Jean-Philippe
    Denis, Philippe
    Lachkar, Yves
    Sellem, Eric
    Rouland, Jean-Francois
    Jeanbat, Viviane
    Bouee, Stephane
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (01) : 47 - 54
  • [6] Preoperative Nonsteroidal Anti-inflammatory Drug or Steroid and Outcomes after Trabeculectomy A Randomized Controlled Trial
    Breusegem, Christophe
    Spielberg, Leigh
    Van Ginderdeuren, Rita
    Vandewalle, Evelien
    Renier, Charlotte
    Van de Veire, Sara
    Fieuws, Steffen
    Zeyen, Thierry
    Stalmans, Ingeborg
    [J]. OPHTHALMOLOGY, 2010, 117 (07) : 1324 - 1330
  • [7] Grading of corneal and conjunctival staining in the context of other dry eye tests
    Bron, AJ
    Evans, VE
    Smith, JA
    [J]. CORNEA, 2003, 22 (07) : 640 - 650
  • [8] Role of Th17 cells in the immunopathogenesis of dry eye disease
    Chauhan, S. K.
    Dana, R.
    [J]. MUCOSAL IMMUNOLOGY, 2009, 2 (04) : 375 - 376
  • [9] Establishment of a Rabbit Model for Keratoconjunctivitis Sicca
    Chen, Zhi-yuan
    Liang, Qing-feng
    Yu, Guang-yan
    [J]. CORNEA, 2011, 30 (09) : 1024 - 1029
  • [10] Cordeiro M F, 2000, Curr Opin Ophthalmol, V11, P121, DOI 10.1097/00055735-200004000-00010